baber/WOPTO huggingface dataset:
Patent AU-2019352676-A1 (AU)
Title: Printhead cradle with longitudinal rail engaging printhead overhead hanger
Inventor: BURKE DAVID
IPC: B41J29/377
Filed: 2019-09-16
Abstract: A print module includes: a cradle defining a longitudinal cavity and an access opening at a first end of the longitudinal cavity; a printhead carrier positioned in the longitudinal cavity, the printhead carrier having a longitudinal rail; and an elongate printhead having a longitudinal overhead hanger for complementary longitudinal sliding engagement with the rail. The printhead is removable from the cradle via longitudinal sliding movement of the printhead relative to the printhead carrier through the access opening.
Patent AU-2019362010-A1 (AU)
Title: 2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating α-synucleinopathies, tauopathies, and other disorders
Inventor: HINMAN ANDREW W
IPC: A61P25/28
Filed: 2019-10-17
Abstract: Disclosed herein are methods of treating or suppressing a disorder selected from the group consisting of α-synucleinopathies, tauopathies, ALS, traumatic brain injury, and ischemic-reperfusion related injuries.ury, comprising administering to a subject in need thereof a therapeutically effective amount of a compound of the formula: or the hydroquinone form thereof; or a solvate or hydrate thereof.
Patent AU-2019362874-A1 (AU)
Title: Programmable DNA base editing by Nme2Cas9-deaminase fusion proteins
Inventor: SONTHEIMER ERIK J
IPC: C12N9/22
Filed: 2019-10-15
Abstract: The present invention is related to the field of gene editing. In particular, the gene editing is directed toward single nucleotide base editing. For example, such single nucleotide base editing results in a conversion of a OG base pair to a T*A base pair. The high accuracy and precision of the presently disclosed single nucleotide base gene editor is accomplished by an NmeCas9 nuclease that is fused to a nucleotide deaminase protein. The compact nature of the NmeCas9 coupled with a larger number of compatible protospacer adjacent motifs provide the Cas9 fusion constructs contemplated herein to have a gene editing window that can edit sites that are not targetable by other conventional SpyCas9 base editor platforms.
Patent AU-2019379141-A1 (AU)
Title: Gene therapy for neuronal ceroid lipofuscinoses
Inventor: KONDRAGUNTA BHARGAVI
IPC: A61K48/00
Filed: 2019-11-13
Abstract: Provided herein are methods and compositions for treatment of Batten disease. Such compositions include a recombinant adeno-associated virus (rAAV), said rAAV comprising an AAV capsid, and a vector genome packaged therein, said vector genome comprising (a) an AAV 5' inverted terminal repeat (ITR) sequence; (b) a promoter; (c) a CLN2 coding sequence encoding a human TPP1; (d) an AAV 3' ITR. Also provided herein are methods of treating Batten disease comprising administering to a subject in need thereof the rAAV described herein via more than one route. Also provide herein are pharmaceutical compositions comprising the rAAV described herein and related methods of treating Batten disease.
Patent AU-2019386959-A1 (AU)
Title: Centralizing and protecting sabot
Inventor: CHENG SAMUEL HEUNG YEUNG
IPC: E21B33/12
Filed: 2019-11-25
Abstract: A system for setting a seal (200, 300, 400) in a wellbore includes a sabot (230, 330, 412) being supported by the seal (200, 300, 400) and having a first diameter (232, 332, 414) larger than a second diameter (222, 322, 420) of the seal (200, 300, 400). The system also includes a bridge (240, 340, 424) coupled to the sabot (230, 330, 412), the bridge (240, 340, 424) extending axially away from the sabot (230, 330, 412) and positioned within a slot (228, 328) formed by an extension (212, 312, 418). The system also includes an energizing ring (308, 402) that applies a radial force to a leg (206, 306, 404) proximate the sabot (230, 330, 412) to at least partially deform the sabot (230, 330, 412).
Patent AU-2019391197-A1 (AU)
Title: Context-based intra prediction
Inventor: ZHANG KAI
IPC: H04N19/50
Filed: 2019-12-05
Abstract: A method for video processing is provided. The method includes performing downsampling on chroma and luma samples of a neighboring block of the current video block; determining, for a conversion between a current video block of a video that is a chroma block and a coded representation of the video, parameters of cross-component linear model (CCLM) based on the downsampled chroma and luma samples obtained from the downsampling; applying the CCLM on luma samples located in a luma block corresponding to the current video block to derive prediction values of the current video block; and performing the conversion based on the prediction values.
Patent AU-2019405839-A1 (AU)
Title: Zeolite and preparation method therefor
Inventor: BYEON TAE BONG
IPC: C01B39/22
Filed: 2019-07-22
Abstract: Provided is a zeolite preparation method comprising the steps of: obtaining a lithium residue including aluminosilicate from a lithium ore in which is lithium oxide is included; adjusting the pH of the lithium residue by washing the lithium residue; controlling the molar ratio (Si/Al) of silicon to aluminum included in the lithium residue; adding an alkaline material to the lithium residue, thereby preparing same in a hydrogel form; and preparing a crystal by crystallizing the lithium residue in the hydrogel form.
Patent AU-2019416324-A1 (AU)
Title: Bispecific antibody for membrane clearance of target receptors
Inventor: LUCA VINCENT C
IPC: C07K16/18
Filed: 2019-12-26
Abstract: Disclosed are bispecific molecules, referred to herein as ubiquibodies, that are able to ubiquitinate target cell surface receptors on a target cell. The ubiquibodies can be engineered from fusion polypeptides comprising 1) variable domains of antibodies that specifically bind a target cell surface receptor and 2) variable domains of antibodies that specifically bind a transmembrane E3 ubiquitin ligase (TMUL). Either or both components of the ubiquibodies can also be engineered from non-antibody scaffolds including but not limited to nanobodies, monobodies, cyclic peptides, small molecules, and designed ankyrin repeat proteins (Darpins).
Patent AU-2019428241-A1 (AU)
Title: Print component with memory circuit
Inventor: GARDNER JAMES MICHAEL
IPC: B41J2/045
Filed: 2019-07-31
Abstract: A memory circuit for a print component including plurality of I/O pads, including a first analog pad and a second analog pad, to connect to a plurality of signal paths which communicate operating signals to the print component, including an analog signal path connected to the first analog pad and the second analog pad, the first analog pad electrically isolated from the second analog pad to interrupt the analog signal path to the print component. The memory circuit further includes a memory component to store memory values associated with the print component, and a control circuit to, in response to a sequence of operating signals received by the I/O pads representing a memory read, provide an analog signal to the analog pad to provide an analog electrical value at the analog pad representing stored memory values selected by the memory read.
Patent WO-2020163922-A1 (WO)
Title: Système de gestion d'équipements sanitaires et procédé de gestion d'équipements sanitaires
Inventor: CUMMINGS STEPHEN JOHN
IPC: G06Q50/06
Filed: 2020-02-17
Abstract: La présente invention concerne un système de gestion d'équipements sanitaires ainsi qu'un procédé correspondant de gestion d'équipements sanitaires avec au moins une installation sanitaire, qui est couplée à une arrivée d'eau et/ou est incluse dans un circuit d'approvisionnement en eau et au sujet de laquelle au moins une valeur de fonctionnement peut être enregistrée, un dispositif de commande d'équipement sanitaire, connecté à la ou aux installations sanitaires et comprenant au moins un émetteur de données et au moins un récepteur de signaux, et un système de traitement de données et de sortie de signaux communiquant avec le dispositif de commande d'équipement sanitaire via le ou les émetteurs de données et le ou les récepteurs de signaux, le système de traitement de données et de sortie de signaux étant un système à apprentissage automatique et/ou un système comprenant un réseau de neurones artificiels et/ou un système expert.
Patent AU-2020200358-A1 (AU)
Title: Method and system of using standardized structural components
Inventor: VANKER JOHN
IPC: G06F30/13
Filed: 2020-01-17
Abstract: Abstract A method and system disclosed herein provides generating an architectural diagram describing an architectural layout of a building, wherein one or more walls of the building are designated as standardized structural walls, automatically positioning each of the 5 standardized structural walls to a geometric grid, and mapping (or "placing"), using a computer, one or more of a plurality of standardized structural components, including standardized panels, standardized columns, and standardized trusses to coordinates of the geometric grid. 1616 10 116
Patent AU-2020200489-A1 (AU)
Title: Stereochemically enriched compositions for delivery of nucleic acids
Inventor: DEROSA FRANK
IPC: A61K31/495
Filed: 2020-01-23
Abstract: Provided, in part, is a composition comprising one or more chemical entities of formula I, each of which is a compound of formula (I):a pharmaceutically acceptable salt thereof, a solvate thereof, or a solvate of a pharmaceutically acceptable salt thereof, the composition characterized in that greater than a first threshold amount of the total amount of chemical entities of formula I in the composition: are chemical entities of formula I.a, wherein the first threshold amount is 50%; or are chemical entities of formula I.b.1, wherein the first threshold amount is 25%; or are chemical entities of formula I.b.2, wherein the first threshold amount is 25%, wherein the chemical entities of formula I.a, I.b.1, and I.b.2, are described herein, and methods of using such compositions, for example, for the delivery of a polynucleotide in vivo. See Fig. 1
Patent AU-2020201634-A1 (AU)
Title: Systems, devices and methods for analyte monitoring system
Inventor: BURNETTE DOUGLAS WILLIAM
IPC: A61B5/1495
Filed: 2020-03-05
Abstract: Systems and methods are provided for detecting changes or fluctuations in an analyte concentration signal that are abnormal, e.g., exceed a predetermined threshold, current trend of analyte concentration measurements, etc. Signals indicative of an analyte concentration in a host may be received from an analyte sensor. The signals may be monitored, and a determination can be made as to whether there is a change in the signal. Upon detecting such a change, the change can be compensated for such that a representation of the signal indicates the analyte concentration. Optionally, the cause of the detected changes or fluctuations can also be determined and information regarding the detected changes or fluctuations can be recorded and analyzed for subsequent optimization of the systems and methods as well for transmitting alerts, notifications, etc. to a user to take corrective action. sill m **) *ill Ct! 00 Co C?) r 4~t n Co 'N C?) S .7 y r * Co r A iz ~x 3" '"-'C-' "C-' '"-'C-"- 'C'" 'C,-' (N A r o '~'~"'"ki~~ 42> $>~ C-'> 'C-' \ ½. '-C--' <4"-' 'C-' <,C' 2<?) ~ ,-~ 3" 4 ~ ~ ~ 4 ____ (N * (N r (N
Patent AU-2020203264-A1 (AU)
Title: Quiet hours for notifications
Inventor: CHAUDHRI IMRAN A
IPC: H04M1/72451
Filed: 2020-05-19
Abstract: In some implementations, a computing device can be configured to automatically tum off notifications when generating a notification would cause a disturbance or be unwanted by a user. The device can be configured with quiet hours during which notifications that would otherwise be generated by the computing device can be suppressed. In some implementations, quiet hours can be configured as a time period with a start time and an end time. In some implementations, quiet hours can be derived from application data. For example, calendar data, alarm clock data, map data, etc. can be used to determine when quiet hours should be enforced. In some implementations, the device can be configured with exceptions to quiet hour notification suppression. In some implementations, the user can identify contacts to which the quiet hours notification suppression should not be applied.
Patent AU-2020204041-A1 (AU)
Title: Door leaf of a door assembly of a vehicle
Inventor: VAN RYSWYK LÉO
IPC: B61D19/02
Filed: 2020-06-17
Abstract: The invention relates to a door leaf of a door assembly of a vehicle, in which at least 
one door leaf (10) is movable relative to a door frame having a door aperture, wherein 
5 the at least one door leaf (10) can be moved into a closed position, which closes the 
door aperture, and into an open position, which exposes the door aperture, as well as 
into any desired intermediate positions between the closed position and the open 
position, and wherein the at least one door leaf (10) has the following: a door outer 
skin (01), which faces an outer area of the vehicle, a door inner skin (06), which faces 
0 the inner area of the vehicle, at least one door core element (02, 05), arranged in such 
a way between the door outer skin (01) and the door inner skin (06) that the door outer 
skin (01), the door inner skin (06) and the at least one door core element (02, 05) form 
a sandwich structure.  
According to the invention, it is envisaged that at least the door outer skin (01) and the 
5 door inner skin (06) are composed partially or completely of stainless steel, wherein, 
when viewed in the peripheral direction, an outer edge or rim region (08) of the door 
leaf (10) is covered partially or completely by a bent-over rim (09) of the door outer 
skin (01) and/or by a bent-over rim (11) of the door inner skin (06), and/or by at least 
one separate edge or rim cap (04) composed of stainless steel.
Patent AU-2020205913-A1 (AU)
Title: Method executed by user equipment, and user equipment
Inventor: ZHANG CHONGMING
IPC: H04L1/18
Filed: 2020-01-09
Abstract: Provided by the present invention are a method executed by a user equipment (UE) and a UE, the method comprising: receiving control information from a base station, the control information comprising a resource configuration related to the transmission of a physical sidelink shared channel (PSSCH); transmitting data to other UEs by means of the PSSCH according to the control information; and transmitting to the base station first feedback information related to transmission on the PSSCH and/or second feedback information related to transmission on a physical downlink shared channel (PDSCH) between the base station and the UE. Thus, the reliable transmission of data may be implemented, which may thereby increase the reliability and stability of a whole communication system.
Patent AU-2020210153-A1 (AU)
Title: Compositions and methods for treatment of abnormal cell growth
Inventor: PADVAL MAHESH
IPC: A61P35/00
Filed: 2020-07-27
Abstract: COMPOSITIONS AND METHODS FOR TREATMENT OF ABNORMAL CELL GROWTH 
ABSTRACT 
This invention relates to oral dosage forms and methods that are useful in the treatment of 
abnormal cell growth, such as cancer, in mammals, especially humans.
Patent AU-2020210266-A1 (AU)
Title: Extended release injectable formulations comprising an isoxazoline active agent, methods and uses thereof
Inventor: CADY SUSAN MANCINI
IPC: A61K31/422
Filed: 2020-07-30
Abstract: OF THE DISCLOSURE 
This invention relates to extended release injectable formulations for combating parasites 
in animals, comprising at least one isoxazoline active agent, a pharmaceutically acceptable 
polymer, and a solvent. This invention also provides for improved methods for eradicating, 
controlling, and preventing parasite infections and infestations in an animal comprising 
administering the extended release injectable formulations of the invention to the animal in need 
thereof.
Patent AU-2020217185-A1 (AU)
Title: Porous carbon fiber and fluid separation membrane
Inventor: KONDO DAI
IPC: D01F9/22
Filed: 2020-01-30
Abstract: The present invention provides a porous carbon fiber which has an excellent permeation amount and excellent pressure resistance, is prevented from the occurrence of detachment or cracking at an interface, and can exhibit excellent properties needed for use as a support for a fluid separation membrane. The present invention is a porous carbon fiber having a bicontinuous porous structure, wherein the average value R
Patent AU-2020220084-A1 (AU)
Title: Microbiota restoration therapy (MRT) compositions and methods of manufacture
Inventor: JONES LEE A
IPC: A61P1/00
Filed: 2020-08-18
Abstract: Microbiota restoration therapy (MRT) compositions (e.g., oral MRT compositions) 
and methods for manufacturing MRT compositions are disclosed. An example method for 
manufacturing an MRT composition may include collecting a stool sample, purifying the 
stool sample to form a purified sample, stabilizing the purified sample to form a stabilized 
sample, converting the stabilized sample to a solid, adding one or more additives and/or 
excipients to the solid to form a treatment composition, and encapsulating the treatment 
composition.
Patent AU-2020220166-A1 (AU)
Title: Section control system
Inventor: TRUSHIN ALEXANDER
IPC: A01C7/06
Filed: 2020-08-20
Abstract: An assembly to distribute flowable particulate material, the assembly including: a conduit to 
which the material is delivered and to which an airstream is supplied to move the material along 
the conduit to a delivery downstream destination; material delivery means connected to the 
conduit for delivery of material to the downstream destination; control means operatively 
associated with the material delivery means to selectively deliver a pre-determined rate of the 
material to a separator to engage the airstream to concentrate the material in a portion of the 
airstream, the separator being positioned within the conduit upstream of the material delivery 
means; air distribution means in constant fluid communication with the separator and the 
material delivery means to control airflow to the material delivery means.
3/6 
ID(O) 
rs 
113 
1400 
09o 
FIG. 3
Patent AU-2020222295-A1 (AU)
Title: Pharmaceutical combination comprising TNO155 and a PD-1 inhibitor
Inventor: CHEN YING-NAN PAN
IPC: A61P35/00
Filed: 2020-02-10
Abstract: The present invention relates to a pharmaceutical combination comprising TNO155 and a PD-1 inhibitor; pharmaceutical compositions comprising the same; and methods of using such combinations and compositions in the treatment or prevention of conditions in a SHP2 inhibitor combined with PD-1 inhibition is beneficial in, for example, the treatment of cancers.
Patent AU-2020223230-A1 (AU)
Title: Aqueous slurries, coatings and coated articles with hydrophobic inorganic particles and metal salts
Inventor: SHAN GUOBIN
IPC: C09D5/00
Filed: 2020-02-13
Abstract: The invention relates to inorganic particle slurries and coated articles having hydrophobic inorganic particles and at least one metal salt, wherein the hydrophobic inorganic particles are inorganic particles having a hydrophobic coating selected from the group consisting of polyols, organosiloxanes, organosilanes, alkylcarboxylic acids, alkylsulfonates, organophosphates, organophosphonates, fluoropolymers, fluorosurfactants, and mixtures thereof, and wherein the metal of the metal salt is selected from the group consisting of barium, cobalt, zinc, tin, lead, copper, calcium, titanium, zirconium, magnesium, and aluminum. The combination of hydrophobic inorganic particles and metal salts provides synergistic effects in stain migration prevention, protective, and light scattering properties.
Patent AU-2020225319-A1 (AU)
Title: New recombinant diamine oxidase and its use for the treatment of diseases characterized by excess histamine
Inventor: Böhm Thomas
IPC: C12N15/53
Filed: 2020-02-18
Abstract: The invention refers to a recombinant human diamine oxidase (DAO) with decreased glycosaminoglycan binding affinity, wherein said DAO comprises at least one amino acid modification in the glycosaminoglycan (GAG) binding domain. The present invention also refers to the use of the DAO in the treatment of a condition associated with excess histamine, specifically in the treatment of chronic allergic diseases, more specifically in the treatment of anaphylaxis, anaphylactic shock, chronic urticaria, acute urticaria, asthma, hay fever, allergic rhinitis, allergic conjunctivitis, histamine intoxication, headache, atopic dermatitis inflammatory diseases, mastocytosis, mast cell activation syndrome (MCAS), pre-eclampsia, hyperemesis gravidarum, pre-term labor, peptic ulcers, acid reflux, pruritus, and sepsis.
Patent AU-2020233678-A1 (AU)
Title: Multi-use blood control safety catheter assembly
Inventor: HARDING WESTON
IPC: A61M5/32
Filed: 2020-09-16
Abstract: A catheter assembly comprises a catheter (18), a needle (12) having a sharp distal tip 
disposed within the catheter (18), a catheter hub (14) connected to the catheter (18) having 
the needle (12) passing therethrough, the catheter hub (14) including a valve (38) that 
selectively permits or blocks a flow of fluid through the catheter (18), a valve actuator (54) 
that moves between a first position and a second position, and a return member (56) that 
returns the valve actuator (54) from the second position to the first position, and a needle 
protection member (176) that encloses the sharp distal tip of the needle (12).
5/44 
00 
co 
0 t
Patent AU-2020244527-A1 (AU)
Title: Self-supporting, synthetic polymer waterproof membrane with self-healing ability
Inventor: MARTÍN SEVILLA GABRIEL
IPC: C09K3/10
Filed: 2020-10-01
Abstract: SELF-SUPPORTING SYNTHETIC POLYMER WATERPROOFING 
MEMBRANE WITH SELF-REPAIR PROPERTIES 
5 
The self-supporting synthetic polymer waterproofing membrane with self
repairing properties relates to a self-repairing synthetic waterproof membrane, 
applicable in the construction sector. This membrane can be monolayer or 
multilayer. The composition of these membranes comprises thermoplastic 
10 polymers, smectite-type clays and super water-absorbent polymers.
Patent AU-2020266266-A1 (AU)
Title: Preparation of human allogeneic liver-derived progenitor cells
Inventor: STRAGIER PATRICK
IPC: C12N5/071
Filed: 2020-04-30
Abstract: The invention relates to a process for the manufacture of a population of human allogeneic liver-derived progenitor cells (HALPC). The process comprises the use of a xeno- and serum-free culture medium comprising purified native or recombinant human serum albumin.
Patent AU-2020280767-A1 (AU)
Title: Emergency brake valve system for a pneumatic brake system
Inventor: LOUCA SEBASTIAN
IPC: B61H1/00
Filed: 2020-05-14
Abstract: The present invention relates to an emergency brake valve system for a pneumatic brake system of a vehicle, in particular of a rail vehicle. The emergency brake valve system (10) according to the invention has a first valve (11) and a second valve (12). Here, the first valve (11) is configured to conduct an auxiliary pressure (p
Patent AU-2020317713-A1 (AU)
Title: Prestressed concrete
Inventor: AHAGON MASAKI
IPC: E04C2/06
Filed: 2020-09-07
Abstract: [Problem] To provide prestressed concrete that can be widely used as a general construction material, wherein chemical stress induced by an expanding material and mechanical stress induced by a continuous fiber-reinforced wire are simultaneously used, strength is increased due to the synergy of the chemical stress and mechanical stress, lighter and thinner concrete with reduced cracking is achieved, and design freedom is increased. [Solution] The present invention provides prestressed concrete characterized in that, in concrete to which prestressing has been introduced, mechanical stress induced by a tensioning material and chemical stress induced by an expanding material for concrete are simultaneously introduced, said tensioning material being a continuous fiber-reinforced wire, the expanding material for concrete being 5 to 30 kg/m3, and the expanding material containing 0.2 to 2.0 wt% of aluminum oxide.